Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.03644
0.00 (0.00%)
May 26, 2026, 9:30 AM EST
RMTG Revenue
In the year 2025, Regenerative Medical Technology Group had annual revenue of $5.10M with 24.17% growth. Regenerative Medical Technology Group had revenue of $1.57M in the quarter ending December 31, 2025, with 4.04% growth.
Revenue
5.10M
Revenue Growth
+24.17%
P/S Ratio
0.09
Revenue / Employee
5.10M
Employees
1
Market Cap
478.78K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.10M | 992.82K | 24.17% |
| Dec 31, 2024 | 4.11M | 1.70M | 70.44% |
| Dec 31, 2023 | 2.41M | 879.73K | 57.49% |
| Dec 31, 2022 | 1.53M | 1.09M | 249.46% |
| Dec 31, 2021 | 437.89K | 382.81K | 694.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SQZ Biotechnologies Company | 12.12M |
| Emmaus Life Sciences | 12.03M |
| Helix BioMedix | 2.07M |
| Lipella Pharmaceuticals | 389.78K |
| CNBX Pharmaceuticals | 40.64K |
| THC Farmaceuticals | 18.52K |
Regenerative Medical Technology Group News
- 2 months ago - RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind - Accesswire
- 6 months ago - RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit - Accesswire
- 7 months ago - RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership - Accesswire
- 8 months ago - RMTG Expands into Brazil with Strategic Representation Agreement - Accesswire
- 8 months ago - RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries - Accesswire
- 8 months ago - RMTG Partners with BKFC as Official Regenerative Medicine Provider - Accesswire
- 9 months ago - RMTG Subsidiary Cellgenic to Host Soft Opening of Advanced Cell Therapy Manufacturing Lab in Cancun During September ISSCA Global Summit - Accesswire
- 10 months ago - RMTG Expands to Northern Argentina and Paraguay with New Affiliate Partnership - Accesswire